Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

MBIOMBIO
5 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in MUSTANG BIO INC

Yes. Citadel Advisors holds 59,459 shares of MBIO (Mustang Bio), worth $41,740, as of its Q2 2026 13F filing. It increased the position by 6,259 shares (+11.8%) from Q1 2026. Citadel Advisors has held MBIO since Q4 2025, across 3 quarterly 13F filings.

Current Value

$41,740

Current Shares

59,459

Total Value Change

+$14,931

Total Shares Change

+31,390

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
59,459
+11.8%
$41,7400.0%$0.70
15
2026-Q1
Decreased
53,200
-37.2%
$38,7300.0%$0.73
0
2025-Q4
New
84,765
-
$83,1540.0%$0.98
33
2025-Q3
Exited
0
-100.0%
$00.0%$1.52
0
2025-Q2
New
28,069
-
$26,8090.0%$0.96
30

Other major holders of MBIO: Kestra Advisory Services, LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used